Search for: "In re Nexium Antitrust Litigation"
Results 1 - 20
of 23
Sort by Relevance
|
Sort by Date
27 Sep 2019, 6:00 am
They’re constantly trading off options to shape future rents. [read post]
22 Oct 2018, 5:56 am
(In re Asacol Antitrust Litig.), No. 18-1065, 2018 U.S. [read post]
27 Jul 2017, 12:45 pm
” In re Nexium Antitrust Litig., 777 F.3d 9, 20 (1st Cir. 2015). [read post]
8 Dec 2016, 2:00 am
€ 160 The post USA: In re Nexium (Esomeprazole) Antitrust Litigation, United States Court of Appeals, First Circuit, Nos. 15-2005, 21 November 2016 appeared first on Kluwer Patent Blog. [read post]
11 Nov 2015, 3:56 pm
I have found one trial court case, In re Nexium Antitrust Litigation (D. [read post]
15 May 2015, 4:43 am
Court of Appeals for the First district held in In re Nexium Antitrust Litigation, 2015 WL 265548 (1st Cir., Jan. 21, 2015), that so long as “it will be possible to establish a mechanism for distinguishing the injured from the uninjured class members,” particularly where a proposed class includes a “de minimis” number of uninjured parties, a class may still be certified pursuant to Federal Rule of Civil Procedure 23(b)(3). [read post]
27 Feb 2015, 4:58 am
The decision of the First Circuit in In re Nexium Antitrust Litig., Nos. 14-1521, 14-1522, 2015 U.S. [read post]
12 Feb 2015, 3:15 pm
Foodservice Inc. ( In re U.S. [read post]
6 Feb 2015, 9:18 am
” In re Nexium Antitrust Litigation, 2015 U.S. [read post]
6 Feb 2015, 9:18 am
” In re Nexium Antitrust Litigation, 2015 U.S. [read post]
28 May 2014, 10:31 am
In re AndroGel Antitrust Litigation (No. [read post]
29 Aug 2012, 10:09 pm
” NEXIUM. [read post]
16 Jun 2010, 3:50 pm
But don’t say this directly to the competitor; remind it indirectly, otherwise you have an antitrust problem. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride… [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech patents… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
9 May 2008, 10:30 pm
: (Afro-IP), (Managing Intellectual Property), Rwanda: Four years after AIDS drugs bill passed, first low cost meds may head to Rwanda: (GenericsWeb), US: Abbott’s first quarter lobbying tab hits $880,000: (Patent Docs), US: House Bill would expand federal drug pedigree requirements and preempt state requirements: (FDA Law Blog), US: Purchasing Canadian drugs and patent infringement: Litecubes decision: (Patently-O), US: Neuralstem seeks to reopen stayed patent case… [read post]
28 Apr 2008, 11:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC vacates FTC’s decision that Rambus breached antitrust duty by violating JEDEC patent disclosure rules and orders new trial: (Philip Brooks), (Techdirt), (Ars Technica), (IP Law360), (Peter Zura's 271 Patent Blog), (Hal Wegner), (IPBiz), (IP Law360), UK Court of Appeal rules on whether prior art not in the same design… [read post]
